tbuckley/cabot-search huggingface dataset:
Expression of Angiopoietin-like 4 Fibrinogen-Like Domain increases risk of brain metastases in women with breast cancer
Authors: Dao Van Tu, Guillaume Gapihan, Christophe Leboeuf, Diaddin Hamdan, Jean-Paul Feugeas, Hanene Boudabous, Laurent Zelek, Catherine Miquel, Thuan Van Tran, Catherine Monnot, Sthephane Germin, Anne Janin, Guilhem Bousquet
Journal: Annals of Oncology (2019)
Use of Morphological Early Response Data to Predict Relapse in Teenage and Young Adult (TYA) Patients with Acute Lymphoblastic Leukaemia (ALL)
Authors: Caroline L Furness, Clare Rowntree, Ajay J. Vora, Amy A Kirkwood, Christopher Mitchell, Nicholas Goulden, Anthony V. Moorman, Rachael Hough
Journal: Blood (2015)
Identification of New Rare Sequence Changes in RP Genes in Diamond-Blackfan Anemia and Association of the RPL5 and RPL11 Mutations with Craniofacial and Thumb Malformations
Authors: Hanna T. Gazda, Mee Rie Sheen, Adrianna Vlachos, Valerie Choesmel, Marie-Francoise O’Donohue, Hal Schneider, Natasha Darras, Catherine Hasman, Colin A. Sieff, Peter E. Newburger, Sarah Ball, Edyta Niewiadomska, Michal Matysiak, Jan M. Zaucha, Bertil Glader, Charlotte Niemeyer, Joerg J. Meerpohl, Eva Atsidaftos, Jeffrey M. Lipton, Pierre-Emmanuel Gleizes, Alan H. Beggs
Journal: Blood (2008)
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia
Authors: Bader Alanazi, Chinmay R. Munje, Namrata Rastogi, Andrew J. K. Williamson, Samuel Taylor, Paul S. Hole, Marie Hodges, Michelle Doyle, Sarah Baker, Amanda F. Gilkes, Steven Knapper, Andrew Pierce, Anthony D. Whetton, Richard L. Darley, Alex Tonks
Journal: Leukemia (2019)

Abstract Inappropriate localization of proteins can interfere with normal cellular function and drive tumor development. To understand how this contributes to the development of acute myeloid leukemia (AML), we compared the nuclear proteome and transcriptome of AML blasts with normal human CD34 + cells. Analysis of the proteome identified networks and processes that significantly affected transcription regulation including misexpression of 11 transcription factors with seven proteins not previously implicated in AML. Transcriptome analysis identified changes in 40 transcription factors but none of these were predictive of changes at the protein level. The highest differentially expressed protein in AML nuclei compared with normal CD34 + nuclei (not previously implicated in AML) was S100A4. In an extended cohort, we found that over-expression of nuclear S100A4 was highly prevalent in AML (83%; 20/24 AML patients). Knock down of S100A4 in AML cell lines strongly impacted their survival whilst normal hemopoietic stem progenitor cells were unaffected. These data are the first analysis of the nuclear proteome in AML and have identified changes in transcription factor expression or regulation of transcription that would not have been seen at the mRNA level. These data also suggest that S100A4 is essential for AML survival and could be a therapeutic target in AML.
Pharmacological Inhibition Of Semi-Direct Alloantigen Presentation and The Generation Of Cross-Dressed Antigen Presenting Cells: A Novel approach To Limit Graft Versus Host Disease Following Allogeneic Hematopoetic Stem Cell Transplantation
Authors: Sravanti Rangaraju, Junghwa Choi, Cynthia R. Giver, Edmund K. Waller
Journal: Blood (2013)
Treatment with hERG1 K+ Channel Inhibitors Reduces Acute Myeloid Leukemia Cell Lines Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient Mice and Prolongs Survival of Injected Mice.
Authors: Serena Pillozzi, Emanuele De Lorenzo, Marika Masselli, Olivia Crociani, Emanuele Cilia, Eugenio Torre, Antonio Mugnai, Andrea Becchetti, Annarosa Arcangeli
Journal: Blood (2007)
Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies
Authors: Mohamed A. Kharfan-Dabaja, Rahul Mhaskar, Tea Reljic, Joseph Pidala, Janelle Perkins, Benjamin Djulbegovic, Ambuj Kumar
Journal: Blood (2012)
Quantification of Imatinib in Human Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry: Applications to Therapeutic Drug Monitoring of Patients with Chronic Myelogenous Leukemia.
Authors: Francois-Xavier Mahon, Stéphane Picard, Karine Titier, Franck Nicolini, Dominique Ducint, Nicolas Moore, Gerald Marit, Patrice Berthaud, Mathieu Molimard
Journal: Blood (2005)
Diagnostic and Prognostic Significance of Tryptase in Clinical Hematology: A Single Center Experience from 1070 Patients.
Authors: Wolfgang R. Sperr, Aischa El-Samahi, Michael Girschikofsky, Stefan Winkler, Hans Semper, Hermine Agis, Christian Sillaber, Georg Endler, Helmut Rumpold, Dieter Lutz, Peter Valent
Journal: Blood (2006)
Prognostic Impact of Programmed Cell Death-1-Positive Cells on Follicular Lymphoma Patients Might Diminish in the Rituximab Era
Authors: Hiroyuki Takahashi, Naoto Tomita, Seiji Sakata, Chizuko Hashimoto, Rika Ohshima, Shiro Matsuura, Koji Ogawa, Wataru Yamamoto, Yoichi Kameda, Makiko Enaka, Yoshiaki Inayama, Masao Kasahara, Yoshinori Takekawa, Noboru Onoda, Shigeki Motomura, Kengo Takeuchi, Yoshiaki Ishigatsubo
Journal: Blood (2011)
Targeting β-arrestin2 Enhances Survival in a Murine Model of Chronic Myeloid Leukemia
Authors: Lindsay A.M. Rein, Minyong Chen, Barbara S. Theriot, James W. Wisler, Laura M. Wingler, Richard T. Premont, Wei Chen, Julia K.L. Walker, Robert J. Lefkowitz
Journal: Blood (2013)
Declining Rates of Adverse Events (AEs), Rare Occurrence of Serious AEs (SAEs), and No Unexpected Long-Term Side Effects at 5 Years in Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Initially Treated with Imatinib (IM) in the International Randomized Study of Interferon vs STI571 (IRIS).
Authors: Hagop M. Kantarjian, Richard A. Larson, Francois Guilhot, Stephen G. O’Brien, Brian J. Druker
Journal: Blood (2006)
Changes in Serum Free Light Chain Rather Than Intact Monoclonal Immunoglobulin Levels Predict Outcome with Therapy in Patients with Light Chain Amyloidosis.
Authors: Shaji Kumar, Morie A Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis Buadi, Steven R. Zeldenrust, Marina Ramirez-Alvarado, Nelson Leung, Angela Dispenzieri
Journal: Blood (2009)
Downregulation of THAP11 by Bcr-Abl Promotes c-Myc-Mediated CML Cell Proliferation.
Authors: Daisuke Yokota, Satoki Nakamura, Tomonari Takemura, Isao Hirano, Shinya Fujisawa, Kaori Takeshita, Takaaki Ono, Kazuyuki Shigeno, Kazunori Ohnishi
Journal: Blood (2009)
Haploidentical Peripheral Blood Stem Cell Transplantation after Treosulfan-Based Conditioning and Rapamycin GvHD Prophylaxis in Hodgkin Lymphoma
Authors: Mara Morelli, Lorenzo Lazzari, Francesca Lorentino, Raffaella Greco, Fabio Giglio, Andrea Angelo Assanelli, Magda Marcatti, Serena Camilla Dalto, Sarah Marktel, Raffaella Milani, Michela Giulia Tassara, Maria Teresa Lupo Stanghellini, Chiara Bonini, Jacopo Peccatori, Fabio Ciceri
Journal: Blood (2016)
Specific KIR and HLA Genotypes Affect Outcomes Of Single-Agent Anti-CD20 Immunotherapy Of Follicular Lymphoma
Authors: Bartosz Grzywacz, Amy K Erbe, Wei Wang, Erik A. Ranheim, Jacquelyn A Hank, KyungMann Kim, Lakeesha Carmichael, Songwon Seo, Eneida A Mendonca, Yiqiang Song, Fangxin Hong, Randy D. Gascoyne, Elisabeth Paietta, Sandra J. Horning, Brad S. Kahl, Paul M Sondel
Journal: Blood (2013)
Gold Nanoshells Ablate Prostate Tumors
Authors: Jennifer Abbasi
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Minimal Residual Disease in Patients with Follicular Lymphoma Treated with Obinutuzumab or Rituximab As First-Line Induction Immunochemotherapy and Maintenance in the Phase 3 GALLIUM Study
Authors: Christiane Pott, Eva Hoster, Britta Kehden, Michael Unterhalt, Michael Herold, Richard H van der Jagt, Ann Janssens, Michael Kneba, Jiri Mayer, Chris Pocock, Nathalie Danesi, Günter Fingerle-Rowson, Chris Harbron, Kirsten Mundt, Robert E Marcus, Wolfgang Hiddemann
Journal: Blood (2016)
Expression Profile Analysis of Genes Related to Resistance/Sensibility to Prednisolone, Daunorubicin, L-Asparaginase and Vincristine in Childhood Acute Lymphoblastic Leukemia.
Authors: Vanessa S. Silveira, Carlos A. Scrideli, Daniel A. Moreno, Jose A. Yunes, Silvia R. Brandalise, Silvia Toledo, Maria L.M. Lee, Antonio S. Petrili, Vicente Odoni-Filho, Israel Bendit, Luiz G. Tone
Journal: Blood (2007)
Unique Alterations in the Immunopeptidome of Colorectal Cancer Reflect Specific Transformations in Cancer-Associated Signaling Pathways and Reveal Tumor-Specific HLA-Ligand Modulations
Authors: Sebastian P. Haen, Daniel J. Kowalewski, Joerg Bernhardt, Linus Backert, Daniel Backes, Florian Dengler, Stefan Beckert, Ingmar Koenigsrainer, Hans-Georg Kopp, Oliver Kohlbacher, Alfred Koenigsrainer, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Markus W. Loeffler
Journal: Blood (2016)
High Frequency of Subclonal Myeloid Mutations Can be Found in Large Granular Lymphocyte Leukemia
Authors: Elise LeMelle, Cassandra M. Hirsch, Michael Clemente, Srinivasa Reddy Sanikommu, Vera Adema, Hassan Awada, Bartlomiej P. Przychodzen, Hetty E. Carraway, Alan Lichtin, Mikkael A. Sekeres, Sudipto Mukherjee, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2017)
Responses and Survival Are Not Affected by Cytogenetics In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM) Treated with Single-Agent Carfilzomib
Authors: Andrzej J Jakubowiak, Thomas Martin, Seema B. Singhal, Michael Wang, Ravi Vij, Sundar Jagannath, Sagar Lonial, Vishal Kukreti, Francis Buadi, Lauren Bray, Marcy Vallone, Michael Kauffman, Robert Z. Orlowski, David Samuel diCapua Siegel
Journal: Blood (2010)
NHS bosses must tackle mental health crisis among doctors, says BMA
Authors: Abi Rimmer
Journal: BMJ (2019)

The BMA is calling on employers to sign up to a wellbeing charter to improve doctors’ working lives.

The association commissioned qualitative research to establish which factors contributed to poor mental health among doctors.1 Researchers conducted 30 interviews with doctors from a range of specialties and levels of seniority, as well as two online focus groups with medical students and junior doctors.

They established five key factors that …
A Comparative Pharmacodynamic Study of Anti-Xa Activity To Evaluate the Accumulation Effect of Tinzaparin and Enoxaparin Given at Prophylactic Dose over 8 Days in Medical Elderly Patients with Impaired Renal Function.
Authors: Isabelle Mahé, Claire Bal dit Sollier, Manvel Aghassarian, Karine Lacut, Jean-Jacques Heilmann, Jean- François Bergmann, Ludovic Drouet, Dominique Mottier
Journal: Blood (2005)
Engraftment Effects of Intra Bone Marrow Compared to Intravenous Transplantation of Allogeneic Hematopoietic Stem Cells Following a Reduced Intensity Conditioning in a DLA-Identical Canine Littermate Model
Authors: Juliane Werner, Stephanie Schaefer, Sandra Lange, Christoph Machka, Gudrun Knuebel, Anett Sekora, Catrin Roolf, Hugo Murua Escobar, Heike Vogel, Iris Lindner, Mathias Freund, Christian Junghanss
Journal: Blood (2014)
Maintenance Therapy with 5-Azacytidine (5-AC) after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS): A Dose and Schedule Finding Study.
Authors: Andres O. Soriano, Richard Champlin, Gloria McCormick, Sergio Giralt, Peter Thall, Krishna Komanduri, Muzaffar Qazilbash, Guillermo Garcia-Manero, Marcos De Lima
Journal: Blood (2006)
Factors influencing adherence in a trial of early introduction of allergenic food
Authors: Michael R. Perkin, Henry T. Bahnson, Kirsty Logan, Tom Marrs, Suzana Radulovic, Rebecca Knibb, Joanna Craven, Carsten Flohr, E.N. Mills, Serge A. Versteeg, Ronald van Ree, Gideon Lack, Louise Young, Victoria Offord, Mary DeSousa, Jason Cullen, Katherine Taylor, Anna Tseng, Bunmi Raji, Sarah Byrom, Gillian Regis, Charlie Bigwood, Charlotte Stedman, Sharon Tonner, Emily Banks, Yasmin Kahnum, Rachel Babic, Ben Stockwell, Erin Thompson, Lorna Wheatley, Devi Patkunam
Journal: Journal of Allergy and Clinical Immunology (2019)

BackgroundThe Enquiring About Tolerance (EAT) study examined whether the early introduction of 6 allergenic foods from 3 months of age in exclusively breastfed infants prevented the development of food allergy. The intervention was effective in the per-protocol analysis for allergy to 1 or more foods and for egg and peanut individually, but only 42% of early introduction group (EIG) children met the per-protocol criteria.ObjectiveWe sought to identify which factors were responsible for nonadherence in the EAT study.MethodsFactors influencing adherence within the key early introduction period in the EIG (up to 6 months of age) were divided into enrollment and postenrollment factors, and their association with nonadherence was explored.ResultsIn an adjusted analysis, at enrollment, increased maternal age, nonwhite ethnicity, and lower maternal quality of life were independently and significantly associated with overall nonadherence in the EIG. Enrollment eczema and enrollment serum allergen-specific IgE sensitization to 1 or more foods (≥0.1 kU/L) were not related to overall nonadherence. After enrollment, 2 factors were significantly related to EIG overall nonadherence: parent-reported IgE-type symptoms with infant allergenic food consumption by 6 months of age and reported feeding difficulties by 4 months of age.ConclusionIf early introduction of allergenic foods were to be considered a strategy to prevent food allergy, families of nonwhite ethnicity, those with older mothers, and those with infants with reported feeding difficulties or early-onset eczema would benefit from support to promote early and sustained consumption.Graphical abstract
Langerin (CD207) represents a novel interferon-stimulated gene in Langerhans cells
Authors: Ghizlane Maarifi, Magdalena A. Czubala, Justine Lagisquet, Matthew O. Ivory, Kyra Fuchs, Laure Papin, James C. Birchall, Sébastien Nisole, Vincent Piguet, Fabien P. Blanchet
Journal: Cellular and Molecular Immunology (2019)
Helen Salisbury: Integrated care systems—yet another NHS re-disorganisation
Authors: Helen Salisbury
Journal: BMJ (2019)

I’ve heard recently that the days of our local clinical commissioning group (CCG) are numbered, as it’s about to be swallowed up into a larger body covering the area of three previous CCGs. This will be part of a new integrated care system (ICS), which aims to draw together local council services, hospitals, and community services to provide an efficient and seamless service for patients.

Our CCG has its critics, but what we have works well enough for local GPs and their patients. In the six years since the last NHS reorganisation we’ve built …
hTERT Transcriptional Repression in Acute Myeloid Leukemias
Authors: Valérie Capraro, Linda Zane, Lauriane Kuhn, Jérôme Garin, Perrine Galia, Claude Preudhomme, Eric Gilson, Xavier Thomas, Mohamed Elhamri, Youcef Chelgoun, Nathalie Bonnefoy-Berard, Franck Mortreux, Eric Wattel
Journal: Blood (2008)
Quantitative DNA Real-Time PCR Compared To mRNA and Cytogenetic Assays To Monitor Minimal Residual Disease In Chronic Myeloid Leukemia
Authors: Ilaria Stefania Pagani, Orietta Spinelli, Cristina Pirrone, Diana Pigni, Sara Lupoli, Francesca D'Avila, Matteo Barcella, Chiara Boroni, Tamara Intermesoli, Ursula Giussani, Federica Bolda, Francesco Pasquali, Francesco Lo Curto, Arnalda Lanfranchi, Fulvio Porta, Cristina Barlassina, Alessandro Rambaldi, Giovanni Porta
Journal: Blood (2013)
Outcome of Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: Subgroup Analysis from the UK NCRI R-CHOP 14 Vs 21 Trial
Authors: Andrea Kühnl, David Cunningham, Nicholas Counsell, Eliza A Hawkes, Wendi Qian, Paul Smith, Nick Chadwick, Anthony Lawrie, Paul Mouncey, Andrew S Jack, Christopher Pocock, Kirit Ardeshna, John Radford, Andrew McMillan, John Davies, Deborah Turner, Anton Kruger, Peter W Johnson, Joanna Gambell, David C Linch
Journal: Blood (2015)
STAT3 Inhibition Synergizes with BCR-ABL1 Inhibition to Overcome Kinase-Independent TKI Resistance in Chronic Myeloid Leukemia (CML)
Authors: Anna M. Eiring, Ira L Kraft, Brent DG Page, David J Anderson, Zhimin Gu, Jamshid S Khorashad, Anthony D Pomicter, Kimberly R Reynolds, Matthew S Zabriskie, Richard Moriggl, Patrick T Gunning, Thomas O'Hare, Michael W Deininger
Journal: Blood (2012)
Hypermethylation and Reduced Carnitine Availability - Possible Mechanisms for Downregulation of Microsomal Carnitine Palmitoyltransferase (mCPT) in Myelodysplastic Syndromes (MDS).
Authors: Michael Pfeilstocker, Heidrun Karlic, Peter Wihlidal, Thomas Noesslinger, Elisabeth Pittermann
Journal: Blood (2006)
A Novel Somatic Mutation in IKZF1 Is Common in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant for Myelofibrosis
Authors: Emily Stevens, Isaac C Jenkins, Lan Beppu, Qing Zhang, Keith R Loeb, Rachel Salit, Jerald P. Radich, H. Joachim Deeg
Journal: Blood (2016)
Long Term Psycho-Social Aspects and Risk Factors for Severe Infections, Ocular, Pulmonary, Bone, Thyroid and Other Complications after Allogeneic Hematopoietic Stem Cell Transplantation for Children with Hematologic Malignancies.
Authors: Christèle Ferry, Gladys Gemayel, Vanderson Rocha, Myriam Labopin, Hélène Esperou, Marie Robin, Régis Peffault de Latour, Patricia Ribaud, Agnès Devergie, Eliane Gluckman, Gerard Socie
Journal: Blood (2006)
Chimerism and Tolerance after Combined Human Kidney and Hematopoietic Cell Transplantation Using Conditioning with Total Lymphoid Irradiation and Anti-Thymocyte Globulin.
Authors: Robert Lowsky, Judith Shizuru, Stephan Busque, John Scandling, Minnie Sarwal, Sussan Jones, Claudia Benike, Richard Hoppe, Ed Engleman, Sam Strober
Journal: Blood (2008)
Evaluation of imatinib mesylate (IM) in patients with large volume gastrointestinal stromal tumors (GISTs)
Authors: D. M. Byrd, G. D. Demetri, H. Joensuu, M. von Mehren, M. Heinrich, B. Eisenberg, J. Fletcher, C. Corless, C. Fletcher, D. Heintz, C. D. Blanke
Journal: Journal of Clinical Oncology (2007)

10054 Background: GIST size is one of the most important prognostic markers for recurrence and poor survival. However, little information exists regarding the relationship between tumor volume and clinical outcome after treatment with IM. A phase II randomized clinical trial of two dose levels of IM (400 vs. 600 mg daily) in pts with incurable GIST was previously presented (Proc ASCO 2001; Combined GI Symp 2004 and 2007). With median follow-up of 64 months, we report additional analyses of the relationship between tumor volume and IM efficacy. Methods: Data on initial tumor bulk were prospectively collected, and 146 pts were separated into quartiles according to total tumor volume: &lt; 39.1 cm 2 (n=36), 39.1 = 102.16 cm 2 (n=37), 102.16 = 262.6 cm 2 (n=36), = 262.6 cm 2 (n=37). Tumor bulk was correlated with standard efficacy outcomes. Results: The overall response rate (CR + PR) for all pts was 68.1% (95% CI 59.8% - 75.5%). Median time-to-progression (TTP) was 24 months, and overall survival (OS) was 57 months. The overall response rates for the four quartiles according to tumor burden (lowest to highest) were: 64%, 70%, 75%, and 65% respectively. Median TTP by quartile was: 57, 25, 18, and 17 months. Median OS for these same groups: not reached, 57, 47, and 35 months. The Kaplan-Meier estimates of patients alive at 64 months based on tumor bulk were 62%, 40%, 44%, and 31% respectively. Disease bulk was an independent prognostic factor for overall survival using a Cox regression model including sex, performance status, IM dose, gender, age, prior chemotherapy, and tumor volume, but not when baseline hemoglobin was included. Conclusions: Pts with bulky GISTs progress sooner and die more quickly than those with lesser tumor volumes, though other factors may contribute as well. Even pts with the bulkiest tumors frequently respond to treatment with IM, however. TTP for this population approaches 1.5 yrs, and median survival for these pts approximates 3 yrs. One-third of pts with extraordinarily bulky GISTs are long-term survivors. The potential relationship between baseline hemoglobin and tumor bulk requires further investigation. [Table: see text]
Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.
Authors: Adalberto Ibatici, AnnaMaria Raiola, Marina Podesta, Francesca Gualandi, Nadia Sessarego, Alessia Parodi, Silvia Luchetti, Sarah Pozzi, Valeria Pinto, Giovanna Piaggio, Marco Gobbi, Andrea Bacigalupo, Francesco Frassoni
Journal: Blood (2007)
Mathematical Modeling of Patient-Level Hemoglobin Delineates Ruxolitinib’s Complex Mechanism of Action and Quantifies Anemia Risk
Authors: Celine Sarr, Shweta Urva, Jerry Nedelman, William Sallas, Viktoriya Stalbovskaya, Prashanth Gopalakrishna, Dany Habr, Renaud Capdeville
Journal: Blood (2014)
Low-Dose Rituximab in Idiopathic Autoimmune Hemolytic Anemia.
Authors: Wilma Barcellini, Francesco Zaja, Anna Zaninoni, Francesca Guia Imperiali, Marta Battista, Carla Filí, Domenico Russo, Eros Di Bona, Dario Consonni, Alberto Zanella
Journal: Blood (2009)
Overexpression of SIRT1, a Longevity Gene-Encoded Protein, and Induction of Apoptosis by Its Inhibition In Adult T-Cell Leukemia Cells
Authors: Tomohiro Kozako, Makoto Yoshimitsu, Yohann White, Akiyoshi Aikawa, Teruhisa Shoji, Shinichiro Honda, Hiroshi Shimeno, Shinji Soeda, Naomichi Arima
Journal: Blood (2010)
Allogeneic Stem Cell Transplantation From Matched Related Donor in Patients Over the Age of 55 Years: A Prospective Multicenter Phase II Study of a Reduced Intensity Conditioning Associating Fludarabin-IV Busulfan and Thymoglobulin
Authors: Didier Blaise, Mohamad Mohty, Noel Milpied, Anne Gaelle Lecorroller, Nathalie Fegueux, Sabine Furst, Patrice Chevallier, Reza Tabrizi, Mauricette Michallet, Jean Yves Cahn, Anne Sirvent, Jacques-Olivier Bay, Jean El Cheikh, Catherine Faucher, Roberto Crocchiolo, Agnes Boyer-Chamard, Luca Castagna, Jean Marie Boher
Journal: Blood (2011)
Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis
Authors: Kate E Hodgson, Gerardo Ferrer, Carmen Martinez, Manel Juan, Tycho Baumann, Montserrat Rovira, Marta Aymerich, Laura Carretero, Francesc Bosch, Alvaro Urbano, Emili Montserrat, Carol Moreno
Journal: Blood (2010)
Post-Remission Therapy with Imatinib and HAM Improve MRD before Tansplant for Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL): Results of the GRAALL AFR03 Study.
Authors: Thibaut Leguay, Francis Witz, Stéphane De Botton, Jean Gabert, Jean-Michel Cayuela, Elizabeth Macintyre, Claude Preudhomme, Nathalie Fegueux, Xavier Thomas, Jean-Yves Cahn, Martine Escoffre, Andre Delannoy, Norbert Ifrah, Herve Dombret, Arnaud Pigneux
Journal: Blood (2006)